Enzalutamide: a new indication for nonmetastatic castration-resistant prostate cancer
Jeanny B. Aragon‐Ching(Inova Fairfax Hospital), Brinda Gupta(Georgetown University), LoganP Rhea(Inova Fairfax Hospital)
Cited by 1
Related Papers
Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma
|New England Journal of Medicine|2020|1.5k
American Cancer Society prostate cancer survivorship care guidelines
|CA A Cancer Journal for Clinicians|2014|402
Avelumab First-Line Maintenance for Advanced Urothelial Carcinoma: Results From the JAVELIN Bladder 100 Trial After ≥2 Years of Follow-Up
|Journal of Clinical Oncology|2023|210
Prospective Assessment of Pediatrician-Diagnosed Food Protein–Induced Allergic Proctocolitis by Gross or Occult Blood
|The Journal of Allergy and Clinical Immunology In Practice|2020|101
Improving the Radiosensitivity of Radioresistant and Hypoxic Glioblastoma
|Future Oncology|2010|60